ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 70929 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 70929; 2) Community: the network communities that were significantly associated with the response to NSC 70929; 3) Molecule: the relationships between components within communities and NSC 70929; 4) MDR: the compounds that were significantly associated with the NSC 70929.

NSC Compound Enrichment Correlation
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0194362855512951 0.28028943
NSC 113943 6-Bromosangivamycin 0.0194362855512953 0.10404757
NSC 355644 Anthrapyrazole derivative 0.0194362855512953 0.31328818
NSC 639521 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride 0.0194362855512953 0.25585088
NSC 689865 Null 0.0194362855512953 0.050008628
NSC 699936 Null 0.0194362855512953 -0.022038515
NSC 700124 Null 0.0194362855512953 0.10143914
NSC 723741 Diethyl N-[4-[(3-phenyl-5,7-diaminoquinoxalin-2-yl)hydroxy]benzoyl]- L-glutamate 0.0195559279909782 -0.039449069
NSC 102627 Yoshi 864 0.0195559279909783 0.35331954
NSC 10660 Null 0.0195559279909783 0.26177383
Total:63  Current:23    [First] [Prev] [Next] [Last]